Legal Representation
Attorney
Janina Gorbach
USPTO Deadlines
Next Deadline
121 days remaining
NOA E-Mailed - SOU Required
Due Date
April 22, 2026
Extension Available
Until October 22, 2026
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 26, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 25, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Aug 25, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Aug 25, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 20, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 20, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 19, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 19, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 22, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 27, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 27, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 7, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 24, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 18, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 30, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 10, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; Pharmaceutical preparations for the treatment of sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions
Classification
International Classes
005